Search Items: ACTIVE SURVEILLANCE, . hits: 15
Appelman-Dijkstra, NM; Pilz, S
Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy.
J Clin Endocrinol Metab. 2023; 108(6):1505-1513
Doi: 10.1210/clinem/dgac734
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Malik, AA; Aziz, F; Beshyah, SA; Aldahmani, KM
Characteristics and management of papillary thyroid microcarcinoma in the United Arab Emirates: Experience from a large tertiary hospital
SAUDI J MED MED SCI. 2022; 10(1): 42-48.
Doi: 10.4103/sjmms.sjmms_393_21
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pratsinis, M; Fankhauser, C; Pratsinis, K; Beyer, J; Bührer, E; Cathomas, R; Fischer, N; Hermanns, T; Hirschi-Blickenstorfer, A; Kamradt, J; Alex, Kluth, L; Zihler, D; Mingrone, W; Müller, B; Nestler, T; Rothschild, SI; Seifert, B; Templeton, AJ; Terbuch, A; Ufen, MP; Woelky, R; Gillessen, S; Rothermundt, C
Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.
Eur Urol Open Sci. 2022; 40: 16-18.
Doi: 10.1016/j.euros.2022.03.013
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Regouc, M; Belge, G; Lorch, A; Dieckmann, KP; Pichler, M
Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer.
Cancers (Basel). 2020; 12(3): 749
Doi: 10.3390/cancers12030749
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Rothermundt, C; Thurneysen, C; Cathomas, R; Müller, B; Mingrone, W; Hirschi-Blickenstorfer, A; Wehrhahn, T; Ruf, C; Rothschild, S; Seifert, B; Terbuch, A; Grassmugg, T; Woelky, R; Fankhauser, C; Kunit, T; Fischer, NF; Inauen, R; Kamradt, J; Ziegler, K; Haynes, A; Jüni, P; Gillessen, S
Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
SWISS MED WKLY. 2018; 148(4): w14640-w14640.
Doi: 10.4414/smw.2018.14640
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wendler, JJ; Damm, R; Liehr, UB; Brunner, T; Pech, M; Schostak, M
[Small renal cell carcinoma-active surveillance and ablation].
Urologe A. 2018; 57(6):731-743
Doi: 10.1007/s00120-018-0677-4
Web of Science
PubMed
FullText
FullText_MUG
Wendler, JJ; Liehr, BU; Damm, R; Powerski, M; Brunner, T; Schostak, M; Pech, M
Small renal carcinoma: the "when" and "how" of operation, active surveillance, and ablation.
Pol J Radiol. 2018; 83: e561-e568.
Doi: 10.5114/pjr.2018.81282
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Terbuch, A; Posch, F; Annerer, LM; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Gerger, A; Stotz, M
Long-term cardiovascular complications in stage I seminoma patients.
Clin Transl Oncol. 2017; 19(11):1400-1408
Doi: 10.1007/s12094-017-1742-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zollner-Schwetz, I; Zechner, E; Ullrich, E; Luxner, J; Pux, C; Pichler, G; Schippinger, W; Krause, R; Leitner, E
Colonization of long term care facility patients with MDR-Gram-negatives during an Acinetobacter baumannii outbreak.
Antimicrob Resist Infect Control. 2017; 6(2):49-49
Doi: 10.1186/s13756-017-0209-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Augustin, H; Mayerhofer, K; Seles, M; Pummer, K
Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
Urol Int. 2015; 95(2):125-131
Doi: 10.1159/000371895
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Brookman-May, S; Langenhuijsen, JF; Volpe, A; Minervini, A; Joniau, S; Salagierski, M; Roscigno, M; Akdogan, B; Vandromme, A; Rodriguez-Faba, O; Marszalek, M
Management of localized and locally advanced renal tumors. A contemporary review of current treatment options.
Minerva Med. 2013; 104(3):237-259
Web of Science
PubMed
Seiler, D; Randazzo, M; Leupold, U; Zeh, N; Isbarn, H; Chun, FK; Ahyai, SA; Baumgartner, M; Huber, A; Recker, F; Kwiatkowski, M
Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners.
Urology. 2012; 80(3):564-9
Doi: 10.1016/j.urology.2012.04.053
Web of Science
PubMed
FullText
FullText_MUG
Auprich, M; Bjartell, A; Chun, FK; de la Taille, A; Freedland, SJ; Haese, A; Schalken, J; Stenzl, A; Tombal, B; van der Poel, H
Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
Eur Urol. 2011; 60(5):1045-1054
Doi: 10.1016/j.eururo.2011.08.003
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Auprich, M; Chun, FK; Ward, JF; Pummer, K; Babaian, R; Augustin, H; Luger, F; Gutschi, S; Budäus, L; Fisch, M; Huland, H; Graefen, M; Haese, A
Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging.
Eur Urol. 2011; 59(1):96-105
Doi: 10.1016/j.eururo.2010.10.024
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Graefen, M; Ahyai, S; Heuer, R; Salomon, G; Schlomm, T; Isbarn, H; Budäus, L; Heinzer, H; Huland, H
[Active surveillance for prostate cancer].
Urologe A. 2008; 47(3):261-9
Doi: 10.1007/s00120-008-1638-0
Web of Science
PubMed
FullText
FullText_MUG